Loading...
OTC Markets
Totals
Securities
12,312
Dollar Vol
$2.2B
Share Vol
4.4B
Trades
367,351

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

CNBX
CNBX Pharmaceuticals Inc.

Common Stock

0.0006

-0.0001

-14.29%

0.0005 / 0.0006 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 07/10/2025
Delayed (15 Min) Trade Data: 03:42pm 07/10/2025

0.0006

0.00054 - 0.00076

38,013,793

N/A

Real-Time Level 2 Quote
Bid
Ask
MPID
MPID
Bid Price
Bid Price
Size
Size
Time
Time
ETRF
24.90>year
CDEL
21.9203/16
MACM
18.95>year
NITE
18.95>year
CSTI
18.55>year
MPID
MPID
Ask Price
Ask Price
Size
Size
Time
Time
INTL
19.40>year
NITE
19.40>year
MACM
19.43>year
MAXM
20.11>year
CANT
22.05>year
Unlock Real-Time quotes For CNBXFind Out More
Trade Data
Date
Date
Timestamp
Timestamp
Price
Price
$ Change
$ Change
Volume
Volume
07/10/202515:42:00
0.0006
0.00143,000
07/10/202515:41:56
0.00055
-0.0025,000
07/10/202514:41:36
0.0006
0.00100,000
07/10/202514:01:24
0.0006
0.00950,000
07/10/202514:01:11
0.00055
0.0050,000
More Irregular/odd lot trades, which are not considered for the Open, High, Low or Closing prices, are not shown in trade data table.
Company Description
CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells.
Videos

This company has not added any videos

OTCID Market Logo
OTCID
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.